Email
Print
Enteral Feeding Formula Market - Forecast(2024 - 2030)
Enteral Feeding Formula Market Overview
The Enteral Feeding Formula Market is estimated at $6.07 billion in 2023 growing at a CAGR of 6.5% over the forecast period 2024-2030. Enteral Feeding Formula is a liquid food that enters the human body through a tube in the nose, mouth, stomach, or small intestine and contains carbs, fat, protein, micronutrients, and moisture. The rising frequency of chronic conditions like cancer, stroke, multiple sclerosis, dementia, chronic liver disease, Chronic Obstructive Pulmonary Disease (COPD), and diabetes is expected to fuel demand for solutions that help patients with oral intake difficulties. Furthermore, the growth in preterm births is one of the major causes driving up demand for enteral feeding formulas to suit newborns' nutritional needs. Furthermore, the growing number of home health agencies and nursing homes is fueling demand, since these facilities assist patients in their post-surgery recuperation.
Such agencies serve a high number of elderly people who have trouble swallowing, which is predicted to increase the rate of adoption of enteral feeding formulas, boosting market growth. The Enteral Feeding Formula market is witnessing two prominent trends that are reshaping the industry landscape. There is a growing emphasis on personalized nutrition, with manufacturers tailoring formulas to meet specific patient needs, considering factors like age, medical conditions, and nutritional requirements. This trend aligns with the rising demand for precision healthcare. Additionally, there's a notable surge in the development of plant-based and allergen-free enteral feeding formulas, reflecting the broader shift towards healthier and more sustainable dietary choices. As consumers become increasingly conscious of their health and environmental impact, the market is responding by offering innovative, plant-derived alternatives that address both nutritional and ethical considerations, fostering a more inclusive and sustainable healthcare approach.
Report Coverage
The report: “Global Enteral Feeding Formula Market – Forecast (2024-2030)”, by IndustryARC covers an in-depth analysis of the following segments of the Global Enteral Feeding Formula Market.
By Product: Standard Formula (Calorie Dense Products - 1.0 calorie/mL, Calorie Dense Products - 1.2 calorie/mL, Calorie Dense Products - 1.5 calorie/mL, Calorie Dense Products - 2.0 calorie/mL), Specialty Formula (Renal Formulas, Liver Formulas, Diabetes Formulas, Pulmonary Formulas, Immuno Modulatory Formulas, Gastrointestinal Dysfunction Formulas, Others), Blenderized Formula (Fruits, Vegetables, Meat, Seeds and Grains, Dairy, Others), Elemental Formula, Semi-Elemental Formula, Polymeric Formula, Hydrolyzed Formula, Fiber Supplemented Formula, and others.
By Age Category: Adult, and Children.
By Form: Powder, and Liquid.
By Flavor: Flavored (Vanilla, Strawberry, Butter Pecan, and Others), and Unflavored.
By Mode of Delivery: Oral, Gastric (Nasogastric, Oro-Gastric, Gastrostomy), Tans-pyloric (Naso-jejunal, Gastro-jejunostomy, Jejunostomy).
By Application: Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, and Others.
By End User: Hospitals & Clinics, Nursing Homes, Home Care & Hospice Agencies, Others.
By Distribution Channel: Online, Offline (Hospital Pharmacy, Retail Pharmacy, Hypermarket/Supermarket, Convenience Stores, Others).
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia, and Rest of South America), and Rest of the World (Middle East, and Africa).
Key Takeaways
• The North American Enteral Feeding Formula Market held a 35% revenue share in 2023 due to rising chronic diseases like diabetes, cancer, and neurological conditions.
• The market for enteral feeding formulae is predicted to develop as the prevalence of chronic diseases such as cancer, stroke, multiple sclerosis, dementia, and diabetes rises.
• The rise in preterm newborns, which may require enteral feeding to meet nutritional requirements in various settings, is also fueling market expansion.
• Furthermore, an increase in the number of new products launched accelerates the market growth.
Enteral Feeding Formula Market Segment Analysis – By Category:
Based on Category, the adult segment accounted for the largest revenue market share in 2023 in the Global Enteral Feeding Formula Market. This is mainly owing to the growing geriatric population coupled with chronic illness. The use of enteral feeding formulas has grown dramatically as studies demonstrating clinical benefits have emerged, and the practice of using enteral feeding formulas has evolved as well, with the availability of diverse formulas varying in macronutrient concentration and distribution. However, the Children segment is poised to grow with the fastest CAGR of 7.9% in the forecast period 2024-2030 owing to the growing preterm birth. The British Association for Parenteral and Enteral Nutrition has been surveyed to collect data on enteral feeding formulas to better understand the state of affairs of home enteral tube feeding formulas in children to improve access to healthcare professionals and reduce complications. Every year, 15 million babies are born prematurely, according to the World Health Organization (WHO), and preterm birth complications are the leading cause of death among children under the age of five. The increased prevalence of preterm birth complications is driving up demand for enteral feeding formulas.
Enteral Feeding Formula Market Segment Analysis – By Form:
Based on Form, the Liquid segment is accounted for the largest revenue market share in 2023 in the Global Enteral Feeding Formula Market and is poised to grow with the fastest CAGR of 6.8 % in the forecast period 2024-2030. When possible, liquid formulations are preferred as they are easily absorbed and are less likely to cause tube occlusions. These liquid formulas are administered to patients via enteral (gut) routes to provide a partial or sole source of nutrients. The addition of standard enteral liquid feeding formulas to a preadministered LMP solution has been shown to be effective in preventing gastroesophageal reflux events in severe Percutaneous endoscopic gastrostomy (PEG) patients, according to the National Center for Biotechnology Information (NCBI). Several companies, including Nestle, offer a wide range of flavored liquid products for children and adults looking for flavored enteral feeding formulas, including high calorie, very high calorie, high protein, with fibre, and a fibre option which is driving the segment growth.
Enteral Feeding Formula Market Segment Analysis – By Geography:
Based on Geography, the North American Enteral Feeding Formula Market accounted for 35% of revenue share in 2023. This is mainly attributed to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions. According to the American Cancer Society, in 2023, the United States anticipated 1,958,310 new cancer cases and 609,820 cancer-related deaths, averaging about 5,370 cases per day. However, Asia-Pacific is poised to grow with the fastest CAGR of 7.3% in the forecast period 2024-2030. One of the major factors driving regional demand is the rising incidence of preterm births. According to the World Health Organization (WHO), India, China, Nigeria, Pakistan, and Indonesia have the highest number of preterm births. Furthermore, diabetes diagnosis is increasing in India. India is the world's second-largest country, with 1.3 billion people. As per the Indian Council of Medical Research's 2023 report, the prevalence of diabetes in India is estimated to be over 101 million people, with significant implications for public health. high incidence of preterm births in these regions, the market for enteral feeding formulas is expected to grow significantly to address these healthcare challenges. further expanding the market.
Enteral Feeding Formula Market Drivers
Rising Prevalence of Cancer Is Driving the Market Growth:
With the rising prevalence of cancer worldwide, the market for enteral feeding formulas is accelerating. The rising incidence of cancer diseases such as lung, breast, liver, and stomach cancer has resulted in increased mortality. According to the World Health Organization, in 2022, 20 million new cancer cases and 9.7 million deaths occurred worldwide. Around 53.5 million individuals survived five years post-diagnosis. Globally, approximately 1 in 5 people develop cancer in their lifetime, with mortality rates of 1 in 9 for men and 1 in 12 for women. Cancer cachexia affects the majority of cancer patients, resulting in insulin resistance, accelerated lipolysis with body fat loss, increased protein turnover, muscle mass loss, and loss of appetite and weight. Cancer prevalence varies by location. Asia accounts for more than half of all cancer cases, while Europe accounts for one-quarter. Furthermore, as it is extremely difficult for cancer patients to eat food orally, nutrition is the cornerstone for improving their clinical condition. As the treatment progresses, nutrition is provided via enteral feeding tubes, allowing them to maintain their body mass, which is driving the demand for enteral feeding formula and boosting the market growth. Furthermore, research presented at the 2020 Virtual Congress on Clinical Nutrition and Metabolism, the annual conference of the European Society for Clinical Nutrition and Metabolism (ESPEN), demonstrated that Kate Farms' plant-based, oral, enteral formulas (PBEF) can help adult oncology patients maintain or gain weight, allowing them to receive necessary treatment. As a result, the rising incidence and prevalence of cancer contribute to the growth of the market.
Growing Incidence of Chronic Illness is Accelerating the Market Growth:
The enteral feeding formulas market is being driven primarily by the increasing prevalence of metabolic and chronic disorders, and increased patient care expenditure. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the foremost cause of global mortality, claiming 17.9 million lives annually, encompassing heart and blood vessel disorders like coronary and cerebrovascular diseases. Furthermore, low- and middle-income countries account for 80 percent of all deaths. Moreover, as per the National Center for Biotechnology Information, Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a significant health concern in Canada, with a prevalence of 825 per 100,000 in 2023. Forecasted to increase by 2.44% annually, it's anticipated that 470,000 Canadians, comprising 1.1% of the population, will have IBD by 2035. Furthermore, an increase in the number of premature births, as well as growing nutritional deficiencies, such as severe protein and other micronutrient deficiencies in infants and pregnant women, will drive the demand for nutritional requirements, boosting the overall market growth.
Enteral Feeding Formula Market Challenges
Clogging of Enteral Tubes are Posing Challenges to the Market
When large enteral meals, bulking agents, and medications are delivered through relatively small PEG tubes, clogging is common. Internal lumen occlusion and mechanical tube failure are the two types of tube occlusion. Feeding tube clogging can occur in up to 25% of cases. When excessively thick meals and medications are delivered through a relatively thin feeding line, clogging occurs. Because the low pH of stomach juice can cause protein coagulation, repeated gastric aspiration is avoided. Tube obstructions have been linked to poor nutrition and clinical outcomes. A lapse in the patient's eating schedule, for example, could jeopardise adequate nutritional intake. Tube replacement is prohibitively expensive, both financially and in terms of resources. Radiographic confirmation is one of the most accurate and widely used methods for determining enteral feeding tube placement, but it has a cost in terms of time, money, and patient exposure.
Enteral Feeding Formula Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Global Enteral Feeding Formula Market. Global Enteral Feeding Formula Market top 10 companies are: Abbott Laboratories, Nestle SA, Fresenius Kabi AG, B. Braun Melsungen AG, Nutricia, Medtrition, Inc., EN Otsuka Pharmaceutical Co., Ltd., WHOLE Enteral Nourishment, Vonco Products, LLC., Meiji Holdings Co., Ltd. And Others.
- In September 2022, Kate Farms™ launched Adult Standard 1.4, a high-calorie medical formula in chocolate flavor, advancing plant-based nutrition in healthcare. Offering organic ingredients, it caters to diverse dietary needs, aiming for nourishment and taste.
- In May 2023, Otsuka Pharmaceutical Factory introduced a new variant of ENORASⓇ Liquid for Enteral Use, offering an additional 200 kcal/125 mL with delightful coffee and tea flavors. Ideal for feeding tubes and oral administration.
- Feb 2023, Nestlé Health Science and EraCal Therapeutics have joined forces in a research collaboration to discover innovative nutraceuticals for regulating food intake. The Swiss-based partnership seeks to advance the development of solutions in this crucial aspect of health and nutrition.
1. Enteral Feeding Formula Market - Overview
1.1 Definitions and Scope
2. Enteral Feeding Formula Market - Executive Summary
2.1 Key Trends by Age Category
2.2 Key Trends by Form
2.3 Key Trends by Mode of Delivery
2.4 Key Trends by Application
2.5 Key Trends by End User
2.6 Key Trends by Distribution Channel
2.7 Key Trends by Geography
3. Enteral Feeding Formula Market - Comparative Analysis
3.1 Company Benchmarking
3.2 Global Financial Analysis
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis
4. Enteral Feeding Formula Market - Start-up Companies Scenario
4.1 Key Start-up Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Enteral Feeding Formula Market – Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing Business Index
5.3 Case Studies of Successful Ventures
6. Enteral Feeding Formula Market - Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porter’s Five Force Model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Enteral Feeding Formula Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Enteral Feeding Formula Market–By Product (Market Size -$Million/Billion)
8.1 Standard Formula
8.1.1 Calorie Dense Products - 1.0 calorie/mL
8.1.2 Calorie Dense Products - 1.2 calorie/mL
8.1.3 Calorie Dense Products - 1.5 calorie/mL
8.1.4 Calorie Dense Products - 2.0 calorie/mL
8.2 Specialty Formula
8.2.1 Renal Formulas
8.2.2 Liver Formulas
8.2.3 Diabetes Formulas
8.2.4 Pulmonary Formulas
8.2.5 Immuno Modulatory Formulas
8.2.6 Gastrointestinal Dysfunction Formulas
8.2.7 Others
8.3 Blenderized Formula
8.3.1 Fruits
8.3.2 Vegetables
8.3.3 Meat
8.3.4 Seeds and Grains
8.3.5 Dairy
8.3.6 Others
8.4 Elemental Formula
8.5 Semi-Elemental Formula
8.6 Polymeric Formula
8.7 Hydrolyzed Formula
8.8 Fiber Supplemented Formula
8.9 Others
9. Enteral Feeding Formula Market – By Age Category (Market Size - $Million/$Billion)
9.1 Adult
9.2 Children
10. Enteral Feeding Formula Market – By Form (Market Size - $Million/$Billion)
10.1 Powder
10.2 Liquid
11. Enteral Feeding Formula Market– By Flavor (Market Size - $Million/$Billion)
11.1 Flavored
11.2 Vanilla
11.3 Strawberry
11.4 Butter Pecan
11.5 Others
11.6 Unflavored
12. Enteral Feeding Formula Market– By Mode of Delivery (Market Size - $Million/$Billion)
12.1 Oral
12.2 Gastric
12.2.1 Nasogastric
12.2.2 Oro-gastric
12.2.3 Gastrostomy
12.3 Trans-pyloric
12.3.1 Naso-jejunal
12.3.2 Gastro-jejunostomy
12.3.3 Jejunostomy
13. Enteral Feeding Formula Market– By Application (Market Size - $Million/$Billion)
13.1 Oncology
13.2 Gastroenterology
13.3 Neurology
13.4 Diabetes
13.5 Critical Care
13.6 Others
14. Enteral Feeding Formula Market– By End User (Market Size - $Million/$Billion)
14.1 Hospitals & Clinics
14.2 Nursing Homes
14.3 Home Care & Hospice Agencies
14.4 Others
15. Enteral Feeding Formula Market– By Distribution Channel (Market Size - $Million/$Billion)
15.1 Online
15.2 Offline
15.2.1 Hospital Pharmacy
15.2.2 Retail Pharmacy
15.2.3 Hypermarket/Supermarket
15.2.4 Convenience Stores
15.2.5 Others
16. Enteral Feeding Formula Market- By Geography (Market Size - $Million/$Billion)
16.1 North America
16.1.1 U.S
16.1.2 Canada
16.1.3 Mexico
16.2 South America
16.2.1 Brazil
16.2.2 Argentina
16.2.3 Chile
16.2.4 Colombia
16.2.5 Rest of South America
16.3 Europe
16.3.1 Germany
16.3.2 France
16.3.3 UK
16.3.4 Italy
16.3.5 Spain
16.3.6 Russia
16.3.7 Rest of Europe
16.4 Asia Pacific
16.4.1 China
16.4.2 Japan
16.4.3 South Korea
16.4.4 India
16.4.5 Australia & New Zealand
16.4.6 Rest of Asia Pacific
16.5 Rest of the World
16.5.1 Africa
16.5.2 Middle East
17. Enteral Feeding Formula Market - Entropy
18. Enteral Feeding Formula Market – Industry/Segment Competition Landscape
18.1 Market Share Analysis
18.1.1 Global Market Share – Key Companies
18.1.2 Market Share by Region – Key Companies
18.1.3 Market Share by Countries – Key Companies
18.2 Competition Matrix
18.3 Best Practices for Companies
19. Enteral Feeding Formula Market – Key Company List by Country Premium
20. Enteral Feeding Formula Market- Company Analysis
20.1 Abbott Laboratories
20.2 Nestle SA
20.3 Fresenius Kabi AG
20.4 B. Braun Melsungen AG
20.5 Nutricia
20.6 Medtrition, Inc.
20.7 EN Otsuka Pharmaceutical Co., Ltd.
20.8 WHOLE Enteral Nourishment
20.9 Vonco Products, LLC.
20.1 0Meiji Holdings Co., Ltd.
* "Financials would be provided to private companies on best-efforts basis."
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
LIST OF TABLES
1.Global Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 ($M)1.1 Company/Competition Categorization Market 2023-2030 ($M) - Global Industry Research
1.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
1.2 Public Companies Market 2023-2030 ($M) - Global Industry Research
1.3 Private Companies Market 2023-2030 ($M) - Global Industry Research
1.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 ($M)
2.Global Competitive Landscape Market 2023-2030 ($M)
3.Global Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 (Volume/Units)
3.1 Company/Competition Categorization Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 List of key distributors and channel partners Market 2023-2030 (Volume/Units)
3.2 Public Companies Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Private Companies Market 2023-2030 (Volume/Units) - Global Industry Research
3.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 (Volume/Units)
4.Global Competitive Landscape Market 2023-2030 (Volume/Units)
5.North America Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 ($M)
5.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
5.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
5.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
5.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
5.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 ($M)
6.North America Competitive Landscape Market 2023-2030 ($M)
7.South America Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 ($M)
7.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
7.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
7.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
7.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
7.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 ($M)
8.South America Competitive Landscape Market 2023-2030 ($M)
9.Europe Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 ($M)
9.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
9.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
9.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
9.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
9.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 ($M)
10.Europe Competitive Landscape Market 2023-2030 ($M)
11.APAC Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 ($M)
11.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
11.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
11.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
11.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
11.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 ($M)
12.APAC Competitive Landscape Market 2023-2030 ($M)
13.MENA Enteral Feeding Formulas Market-Competitive Analysis Market 2023-2030 ($M)
13.1 Company/Competition Categorization Market 2023-2030 ($M) - Regional Industry Research
13.1.1 List of key distributors and channel partners Market 2023-2030 ($M)
13.2 Public Companies Market 2023-2030 ($M) - Regional Industry Research
13.3 Private Companies Market 2023-2030 ($M) - Regional Industry Research
13.3.1 List of key emerging companies /technology disruptors/innovators Market 2023-2030 ($M)
14.MENA Competitive Landscape Market 2023-2030 ($M)
LIST OF FIGURES
1.US Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)2.Canada Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
3.Mexico Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
4.Brazil Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
5.Argentina Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
6.Peru Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
7.Colombia Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
8.Chile Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
9.Rest of South America Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
10.UK Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
11.Germany Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
12.France Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
13.Italy Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
14.Spain Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
15.Rest of Europe Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
16.China Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
17.India Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
18.Japan Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
19.South Korea Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
20.South Africa Enteral Feeding Formulas Market Revenue, 2023-2030 ($M)
21.North America Enteral Feeding Formulas By Application
22.South America Enteral Feeding Formulas By Application
23.Europe Enteral Feeding Formulas By Application
24.APAC Enteral Feeding Formulas By Application
25.MENA Enteral Feeding Formulas By Application